| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA1964081 | F | PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element firefly luciferase assay. (Class of assay: confirmatory) | 1,025 | cell-based format | PubChem BioAssays | |||
| 2. | ALA1963912 | F | PUBCHEM_BIOASSAY: S16 Schwann cell viability assay (CellTiter-Glo assay). (Class of assay: confirmatory) | 515 | cell-based format | PubChem BioAssays | |||
| 3. | ALA2354221 | F | PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) | 172,532 | assay format | PubChem BioAssays | |||
| 4. | ALA2354254 | F | PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) | 153,867 | assay format | PubChem BioAssays | |||
| 5. | ALA4270933 | F | Antibacterial activity against Bacillus subtilis incubated for 24 hrs by standard broth dilution assay | Bacillus subtilis | 3 | organism-based format | Scientific Literature | ||
| 6. | ALA4270934 | F | Antibacterial activity against Escherichia coli incubated for 24 hrs by standard broth dilution assay | Escherichia coli | 3 | organism-based format | Scientific Literature | ||
| 7. | ALA4270935 | F | Antibacterial activity against Pseudomonas aeruginosa incubated for 24 hrs by standard broth dilution assay | Pseudomonas aeruginosa | 3 | organism-based format | Scientific Literature | ||
| 8. | ALA4270936 | F | Antibacterial activity against Staphylococcus aureus incubated for 24 hrs by standard broth dilution assay | Staphylococcus aureus | 3 | organism-based format | Scientific Literature | ||
| 9. | ALA4303805 | F | Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging | Homo sapiens | 5,612 | organism-based format | SARS-CoV-2 Screening Data 2020-21 | ||
| 10. | ALA4495582 | F | SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate | Severe acute respiratory syndrome coronavirus 2 | 7,212 | assay format | SARS-CoV-2 Screening Data 2020-21 | ||
| 11. | ALA4513082 | F | Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging | Chlorocebus sabaeus | 7,212 | organism-based format | SARS-CoV-2 Screening Data 2020-21 | ||
| 12. | ALA4808149 | B | Enzymatic assay of human HDAC6 with commercial peptide substrate | Homo sapiens | 5,603 | single protein format | Fraunhofer HDAC6 | ||
| 13. | ALA4808150 | B | Enzymatic assay of human HDAC6 with custom peptide substrate | Homo sapiens | 5,603 | single protein format | Fraunhofer HDAC6 | ||
| 14. | ALA5260994 | F | Antifungal activity against Saccharomyces cerevisiae | Saccharomyces cerevisiae | 3 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!